(Ponezumab)Biosimilar Reference Antibody-GS40557 新品

货号：GS40557

Ponezumab is a humanized IgG2 monoclonal antibody, developed as a potential disease-modifying therapy for Alzheimer's disease. Its primary design is to target and bind specifically to amyloid-beta (Aβ) peptides, which are central to the amyloid cascade hypothesis of Alzheimer's pathology. Unlike some antibodies that primarily target amyloid plaques or oligomeric forms, ponezumab exhibits a particular selectivity for the Aβ40 peptide.